Published in J Clin Microbiol on April 01, 2003
Microbial survey of the mummies from the Capuchin Catacombs of Palermo, Italy: biodeterioration risk and contamination of the indoor air. FEMS Microbiol Ecol (2013) 0.99
Unmasking the measles-like parchment discoloration: molecular and microanalytical approach. Environ Microbiol (2014) 0.97
Imaging characteristics of disseminated Geosmithia argillacea causing severe diskospondylitis and meningoencephalomyelitis in a dog. Clin Case Rep (2015) 0.77
Cytological, microbiological and therapeutic aspects of systemic infection in a dog caused by the fungus Phialosimplex caninus. Med Mycol Case Rep (2013) 0.75
Aspergillus atacamensis and A. salisburgensis: two new halophilic species from hypersaline/arid habitats with a phialosimplex-like morphology. Extremophiles (2017) 0.75
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31
Comparison study of broth macrodilution and microdilution antifungal susceptibility tests for the filamentous fungi. Antimicrob Agents Chemother (1996) 5.27
[Mycoses in domestic animals]. Rev Iberoam Micol (2000) 1.03
Disseminated mycoses in a dog by Paecilomyces sp. J Vet Med A Physiol Pathol Clin Med (2000) 0.98
Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species. J Clin Microbiol (2005) 2.83
Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest. J Clin Microbiol (2007) 2.57
Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus. J Clin Microbiol (2005) 2.52
Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count. J Acquir Immune Defic Syndr (2004) 2.11
Transmission of HIV-1 from an obstetrician to a patient during a caesarean section. AIDS (2006) 2.06
Molecular phylogeny of Sporothrix schenckii. J Clin Microbiol (2006) 1.76
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex. Antimicrob Agents Chemother (2006) 1.74
Fusarium oxysporum as a multihost model for the genetic dissection of fungal virulence in plants and mammals. Infect Immun (2004) 1.67
Molecular and phenotypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedosporium dehoogii. J Clin Microbiol (2007) 1.66
Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. AIDS (2006) 1.65
The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study. Liver Transpl (2009) 1.65
Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases. Med Mycol (2009) 1.61
In vitro antifungal susceptibilities of five species of sporothrix. Antimicrob Agents Chemother (2007) 1.60
Pancreatic toxic effects associated with co-administration of didanosine and tenofovir in HIV-infected adults. Lancet (2004) 1.59
Primary human immunodeficiency virus type 1 infection: clinical, virological and immunological characteristics of 75 patients (1997-2003). Enferm Infecc Microbiol Clin (2006) 1.59
Molecular identification and in vitro response to antifungal drugs of clinical isolates of Exserohilum. Antimicrob Agents Chemother (2012) 1.51
Molecular phylogenetic diversity of the emerging mucoralean fungus Apophysomyces: proposal of three new species. Rev Iberoam Micol (2010) 1.40
In vitro antifungal susceptibility of Cryptococcus gattii. J Clin Microbiol (2004) 1.39
Sporothrix luriei: a rare fungus from clinical origin. Med Mycol (2008) 1.38
Molecular and morphological identification of Colletotrichum species of clinical interest. J Clin Microbiol (2004) 1.35
The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patients. Antivir Ther (2007) 1.33
Universal in vitro antifungal resistance of genetic clades of the Fusarium solani species complex. Antimicrob Agents Chemother (2007) 1.31
PCR protocol for specific identification of Candida nivariensis, a recently described pathogenic yeast. J Clin Microbiol (2005) 1.25
Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes. J Clin Microbiol (2002) 1.23
Anticoagulants interfere with PCR used to diagnose invasive aspergillosis. J Clin Microbiol (2002) 1.23
In vitro interactions of approved and novel drugs against Paecilomyces spp. Antimicrob Agents Chemother (2004) 1.22
Sporothrix globosa, a pathogenic fungus with widespread geographical distribution. Rev Iberoam Micol (2009) 1.21
Posaconazole combined with amphotericin B, an effective therapy for a murine disseminated infection caused by Rhizopus oryzae. Antimicrob Agents Chemother (2008) 1.18
Isolation and identification of yeasts associated with vineyard and winery by RFLP analysis of ribosomal genes and mitochondrial DNA. Microbiol Res (2002) 1.17
Correlation between in vitro susceptibility of Scedosporium apiospermum to voriconazole and in vivo outcome of scedosporiosis in guinea pigs. Antimicrob Agents Chemother (2004) 1.16
Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice. Antimicrob Agents Chemother (2003) 1.16
A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression. J Acquir Immune Defic Syndr (2009) 1.16
Presence of Arcobacter spp. in environmental waters correlates with high levels of fecal pollution. Environ Microbiol (2008) 1.15
Prevalence of Arcobacter in meat and shellfish. J Food Prot (2009) 1.14
Correlation of antifungal susceptibility and molecular type within the Cryptococcus neoformans/C. gattii species complex. Med Mycol (2011) 1.13
Actinomucor elegans var. kuwaitiensis isolated from the wound of a diabetic patient. Antonie Van Leeuwenhoek (2008) 1.12
Scopulariopsis, a poorly known opportunistic fungus: spectrum of species in clinical samples and in vitro responses to antifungal drugs. J Clin Microbiol (2013) 1.11
Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies. AIDS (2013) 1.10
Cochlear compression in listeners with moderate sensorineural hearing loss. Hear Res (2005) 1.10
Saksenaea vasiformis infections: case report and literature review. Mycopathologia (2006) 1.09
Genus Hamigera, six new species and multilocus DNA sequence based phylogeny. Mycologia (2010) 1.08
In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases. Antimicrob Agents Chemother (2005) 1.07
Role of the white collar 1 photoreceptor in carotenogenesis, UV resistance, hydrophobicity, and virulence of Fusarium oxysporum. Eukaryot Cell (2008) 1.06
HapX-mediated iron homeostasis is essential for rhizosphere competence and virulence of the soilborne pathogen Fusarium oxysporum. Plant Cell (2012) 1.06
The velvet complex governs mycotoxin production and virulence of Fusarium oxysporum on plant and mammalian hosts. Mol Microbiol (2012) 1.06
Two new species of Mucor from clinical samples. Med Mycol (2010) 1.05
Genotyping of Scedosporium species: a review of molecular approaches. Med Mycol (2008) 1.05
Efficacy of micafungin in combination with other drugs in a murine model of disseminated trichosporonosis. Antimicrob Agents Chemother (2005) 1.05
Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans. Antimicrob Agents Chemother (2009) 1.05
Genotyping of 44 isolates of Fusarium solani, the main agent of fungal keratitis in Brazil. J Clin Microbiol (2004) 1.04
Interaction of granulocyte colony-stimulating factor and high doses of liposomal amphotericin B in the treatment of systemic murine scedosporiosis. Diagn Microbiol Infect Dis (2004) 1.04
In vitro interactions of licensed and novel antifungal drugs against Fusarium spp. Diagn Microbiol Infect Dis (2004) 1.02
Potential virulence and antimicrobial susceptibility of Aeromonas popoffii recovered from freshwater and seawater. FEMS Immunol Med Microbiol (2002) 1.02
Posaconazole efficacy in a murine disseminated infection caused by Paecilomyces lilacinus. J Antimicrob Chemother (2008) 1.01
Combined antifungal therapy in a murine model of disseminated infection by Cladophialophora bantiana. Med Mycol (2008) 1.01
Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection. Antimicrob Agents Chemother (2009) 1.00
Case of keratitis caused by an uncommon Fusarium species. J Clin Microbiol (2003) 1.00
In vitro synergistic interaction between amphotericin B and micafungin against Scedosporium spp. Antimicrob Agents Chemother (2005) 1.00
Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP study. J Acquir Immune Defic Syndr (2009) 0.99
Liposomal amphotericin B and granulocyte colony-stimulating factor therapy in a murine model of invasive infection by Scedosporium prolificans. J Antimicrob Chemother (2002) 0.99
Clinical treatment of corneal infection due to Fonsecaea pedrosoi--case report. Arq Bras Oftalmol (2005) 0.98
In vitro activities of new antifungal agents against Chaetomium spp. and inoculum standardization. Antimicrob Agents Chemother (2003) 0.98
A comprehensive phylogeny of Neurospora reveals a link between reproductive mode and molecular evolution in fungi. Mol Phylogenet Evol (2011) 0.97
Molecular phylogeny of Coniochaetales. Mycol Res (2006) 0.96
Clinical utility of maraviroc. Clin Drug Investig (2011) 0.96
Less-frequent Fusarium species of clinical interest: correlation between morphological and molecular identification and antifungal susceptibility. J Clin Microbiol (2009) 0.96
Efficacy of liposomal amphotericin B in treatment of systemic murine fusariosis. Antimicrob Agents Chemother (2002) 0.95
In vitro and in vivo activities of posaconazole and amphotericin B in a murine invasive infection by Mucor circinelloides: poor efficacy of posaconazole. Antimicrob Agents Chemother (2012) 0.95
Different virulence of the species of the Pseudallescheria boydii complex. Med Mycol (2008) 0.95
Heterothallism in Scedosporium apiospermum and description of its teleomorph Pseudallescheria apiosperma sp. nov. Med Mycol (2010) 0.94
In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum. Antimicrob Agents Chemother (2008) 0.93
Efficacy of voriconazole in a murine model of cryptococcal central nervous system infection. J Antimicrob Chemother (2007) 0.93
Saccharomyces cerevisiae vaginitis: microbiology and in vitro antifungal susceptibility. Mycopathologia (2011) 0.93
Molecular identification and antifungal susceptibility testing of clinical isolates of the Candida rugosa species complex and proposal of the new species Candida neorugosa. J Clin Microbiol (2012) 0.92
New pyrenochaeta species causing keratitis. J Clin Microbiol (2009) 0.92
A new 16S rDNA-RFLP method for the discrimination of the accepted species of Arcobacter. Diagn Microbiol Infect Dis (2007) 0.92